Influences of Crystal Anisotropy in Pharmaceutical Process Development

Area of Science:

• Pharmaceutical Science
• Materials Science
• Physical Chemistry

Background:

• Crystalline materials are essential in pharmaceutical formulations, with properties like anisotropy significantly impacting processes such as milling and tableting.
• Current research often oversimplifies crystalline material behavior, neglecting crucial anisotropic characteristics and the role of interfacial phenomena.
• The influence of interfacial phenomena on crystal behavior during growth and in vivo remains poorly understood.

Purpose of the Study:

• To provide a molecular-level understanding of crystal growth and dissolution processes in pharmaceuticals.
• To highlight the importance of crystal anisotropy and interfacial phenomena in pharmaceutical science.
• To bridge the gap between fundamental concepts and practical applications in rational drug design.

Main Methods:

• Review of fundamental concepts in intermolecular and interfacial phenomena.
• Discussion of the relevance of these concepts to pharmaceutical crystal growth and dissolution.
• Emphasis on mechanistic insights into solvent and additive effects on crystal habit.

Main Results:

• Anisotropic properties of crystals significantly influence pharmaceutical processing.
• Interfacial phenomena play a critical, yet often overlooked, role in crystal behavior.
• Solvents and additives demonstrably impact crystal habit through specific mechanisms.

Conclusions:

• A molecular perspective on crystal anisotropy and interfacial phenomena is crucial for advancing pharmaceutical crystallization.
• Further research integrating fundamental principles of interfacial science will enable rational control over crystal growth and dissolution.
• Understanding these factors is key to optimizing drug formulation and performance.